Jeffrey B. Mirviss - 03 Dec 2021 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: EVP&Pres, Periph Intervent
Signature: /s/ Vance R. Brown, Attorney-in-fact
Issuer symbol: BSX
Transactions as of: 03 Dec 2021
Net transactions value: -$11,680
Form type: 4
Filing time: 06 Dec 2021, 15:38:44 UTC
Previous filing: 27 Jul 2021
Next filing: 03 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Gift	$0	-183	-0.14%	$0.000000	132,935	30 Aug 2021	Direct
transaction	BSX	Common Stock	Gift	$0	-135	-0.1%	$0.000000	132,800	31 Aug 2021	Direct
transaction	BSX	Common Stock	Options Exercise	$0	+649	+0.49%	$0.000000	133,449	03 Dec 2021	Direct	F1
transaction	BSX	Common Stock	Tax liability	$11,680	-296	-0.22%	$39.46	133,153	03 Dec 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Deferred Stock Units	Options Exercise	$0	-649	-33%	$0.000000	1,298	03 Dec 2021	Common Stock	649		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2	Shares of common stock will be issued to the reporting person in five equal annual installments beginning on December 3, 2019, the first anniversary of the date of grant.